<?xml version="1.0" encoding="UTF-8"?>
<p>The first HIV positive sera and AIDS case was diagnosed in Ethiopia in 1984 and 1986, respectively [
 <xref rid="pone.0205446.ref015" ref-type="bibr">15</xref>, 
 <xref rid="pone.0205446.ref016" ref-type="bibr">16</xref>]. By the late 1980s a high prevalence of HIV-1 was detected among commercial sex workers and among long distance truck drivers [
 <xref rid="pone.0205446.ref017" ref-type="bibr">17</xref>]. ART was introduced in the public health sector in 2003, with free ART provision since 2005 [
 <xref rid="pone.0205446.ref018" ref-type="bibr">18</xref>]. In 2017, an estimated ~740,000 individuals were living with HIV and ~426,000 had initiated ART [
 <xref rid="pone.0205446.ref019" ref-type="bibr">19</xref>]. With the scale up and decentralization of the service in Ethiopia, the emergence and transmission of resistance is expected, as has been evident in other LMIC [
 <xref rid="pone.0205446.ref004" ref-type="bibr">4</xref>â€“
 <xref rid="pone.0205446.ref007" ref-type="bibr">7</xref>]. Following the WHO recommendation, Ethiopia implemented a strategy for the prevention and monitoring of HIVDR to maximize the durable efficacy of affordable and potent first-line ART regimens [
 <xref rid="pone.0205446.ref020" ref-type="bibr">20</xref>].
</p>
